{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:15:17Z","timestamp":1791908117198,"version":"4.3.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-69154-0","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:04:15Z","timestamp":1770447855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Combined bacteriophage and antibiotic therapy for refractory peritoneal dialysis-related peritonitis caused by Klebsiella pneumoniae"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5828-7970","authenticated-orcid":false,"given":"Xiaoxiao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1244-0030","authenticated-orcid":false,"given":"Nannan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8675-4513","authenticated-orcid":false,"given":"Yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xialian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"69154_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-med-080219-122208","volume":"73","author":"GF Hatfull","year":"2022","unstructured":"Hatfull, G. F., Dedrick, R. M. & Schooley, R. T. Phage Therapy for Antibiotic-Resistant Bacterial Infections. Annu. Rev. Med. 73, 197\u2013211 (2022).","journal-title":"Annu. Rev. Med."},{"key":"69154_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3747\/pdi.2013.00012","volume":"34","author":"X Feng","year":"2014","unstructured":"Feng, X. et al. Escherichia coli Peritonitis in peritoneal dialysis: the prevalence, antibiotic resistance and clinical outcomes in a South China dialysis center. Perit. Dial. Int. 34, 308\u2013316 (2014).","journal-title":"Perit. Dial. Int."},{"key":"69154_CR3","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/ki.2010.149","volume":"78","author":"EM Jarvis","year":"2010","unstructured":"Jarvis, E. M. et al. Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis. Kidney Int. 78, 408\u2013414 (2010).","journal-title":"Kidney Int."},{"key":"69154_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/089686080302300508","volume":"23","author":"J Vald\u00e9s-Sotomayor","year":"2003","unstructured":"Vald\u00e9s-Sotomayor, J. et al. Increased severity of Escherichia coli peritonitis in peritoneal dialysis patients independent of changes in in vitro antimicrobial susceptibility testing. Perit. Dial. Int. 23, 450\u2013455 (2003).","journal-title":"Perit. Dial. Int."},{"key":"69154_CR5","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1177\/089686080302302s30","volume":"23","author":"N Prasad","year":"2003","unstructured":"Prasad, N. et al. Outcome of gram-positive and gram-negative peritonitis in patients on continuous ambulatory peritoneal dialysis: a single-center experience. Perit. Dial. Int. 23, S144\u2013147 (2003).","journal-title":"Perit. Dial. Int."},{"key":"69154_CR6","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/sj.ki.5000037","volume":"69","author":"CC Szeto","year":"2006","unstructured":"Szeto, C. C. et al. Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases. Kidney Int. 69, 1245\u20131252 (2006).","journal-title":"Kidney Int."},{"key":"69154_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1053\/j.ajkd.2007.11.011","volume":"51","author":"A Zurowska","year":"2008","unstructured":"Zurowska, A. et al. Gram-negative peritonitis in children undergoing long-term peritoneal dialysis. Am. J. Kidney Dis. 51, 455\u2013462 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"69154_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jmii.2013.10.002","volume":"48","author":"WH Lin","year":"2015","unstructured":"Lin, W. H. et al. Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Klebsiella pneumoniae in southern Taiwan. J. Microbiol. Immunol. Infect. 48, 276\u2013283 (2015).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"69154_CR9","first-page":"210","volume":"10","author":"GC Cancarini","year":"1994","unstructured":"Cancarini, G. C. et al. Simultaneous catheter replacement-removal during infectious complications in peritoneal dialysis. Adv. Perit. Dial. 10, 210\u2013213 (1994).","journal-title":"Adv. Perit. Dial."},{"key":"69154_CR10","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1177\/11297298231178061","volume":"25","author":"L Nardelli","year":"2024","unstructured":"Nardelli, L. et al. Simultaneous removal and replacement of the peritoneal catheter in CAPD patient with refractory peritonitis sustained by P. aeruginosa: a case-report. J. Vasc. Access 25, 1341\u20131344 (2024).","journal-title":"J. Vasc. Access"},{"key":"69154_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1159\/000362622","volume":"39","author":"X Yang","year":"2014","unstructured":"Yang, X. et al. Intraperitoneal interleukin-6 levels predict peritoneal solute transport rate: a prospective cohort study. Am. J. Nephrol. 39, 459\u2013465 (2014).","journal-title":"Am. J. Nephrol."},{"key":"69154_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000489271","volume":"47","author":"X Yang","year":"2018","unstructured":"Yang, X. et al. High Intraperitoneal interleukin-6 levels predict peritonitis in peritoneal dialysis patients: a prospective cohort study. Am. J. Nephrol. 47, 317\u2013324 (2018).","journal-title":"Am. J. Nephrol."},{"key":"69154_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/089686089501500208","volume":"15","author":"D Zemel","year":"1995","unstructured":"Zemel, D., Betjes, M. G., Dinkla, C., Struijk, D. G. & Krediet, R. T. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD. Perit. Dial. Int. 15, 134\u2013141 (1995).","journal-title":"Perit. Dial. Int."},{"key":"69154_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S0272-6386(00)70011-4","volume":"35","author":"KN Lai","year":"2000","unstructured":"Lai, K. N. et al. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am. J. Kidney Dis. 35, 644\u2013652 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"69154_CR15","first-page":"686","volume":"122","author":"D Zemel","year":"1993","unstructured":"Zemel, D. et al. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J. Lab. Clin. Med. 122, 686\u2013696 (1993).","journal-title":"J. Lab. Clin. Med."},{"key":"69154_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tim.2010.06.005","volume":"18","author":"IC Sutcliffe","year":"2010","unstructured":"Sutcliffe, I. C. A phylum level perspective on bacterial cell envelope architecture. Trends Microbiol. 18, 464\u2013470 (2010).","journal-title":"Trends Microbiol."},{"key":"69154_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00423-010-0658-6","volume":"395","author":"K Buttenschoen","year":"2010","unstructured":"Buttenschoen, K., Radermacher, P. & Bracht, H. Endotoxin elimination in sepsis: physiology and therapeutic application. Langenbecks Arch. Surg. 395, 597\u2013605 (2010).","journal-title":"Langenbecks Arch. Surg."},{"key":"69154_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/089686080102100208","volume":"21","author":"KO Muhammed","year":"2001","unstructured":"Muhammed, K. O., Ozener, Q. & Akoglu, E. Diagnostic value of effluent endotoxin level in gram-negative peritonitis in CAPD patients. Perit. Dial. Int. 21, 154\u2013157 (2001).","journal-title":"Perit. Dial. Int."},{"key":"69154_CR19","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/nep.12828","volume":"21","author":"CC Szeto","year":"2016","unstructured":"Szeto, C. C. et al. Dialysate bacterial endotoxin as a prognostic indicator of peritoneal dialysis related peritonitis. Nephrology 21, 1069\u20131072 (2016).","journal-title":"Nephrology"},{"key":"69154_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/0896860819896134","volume":"40","author":"H Yan","year":"2020","unstructured":"Yan, H., Ma, D., Yang, S., Ni, Z. & Fang, W. Effluent lipopolysaccharide is a prompt marker of peritoneal dialysis-related gram-negative peritonitis. Perit. Dial. Int. 40, 455\u2013461 (2020).","journal-title":"Perit. Dial. Int."},{"key":"69154_CR21","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","volume":"22","author":"S Uyttebroek","year":"2022","unstructured":"Uyttebroek, S. et al. Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review. Lancet Infect. Dis. 22, e208\u2013e220 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"69154_CR22","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41591-025-03678-8","volume":"31","author":"BK Chan","year":"2025","unstructured":"Chan, B. K. et al. Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis. Nat. Med. 31, 1494\u20131501 (2025).","journal-title":"Nat. Med."},{"key":"69154_CR23","doi-asserted-by":"crossref","unstructured":"Moelling, K., Broecker, F. & Willy, C. A wake-up call: we need phage therapy now. Viruses 10, 688 (2018).","DOI":"10.3390\/v10120688"},{"key":"69154_CR24","doi-asserted-by":"crossref","unstructured":"Philipson, C. W. et al. Characterizing phage genomes for therapeutic applications. Viruses 10, 188 (2018).","DOI":"10.3390\/v10040188"},{"key":"69154_CR25","doi-asserted-by":"crossref","unstructured":"Egido, J. E., Costa, A. R., Aparicio-Maldonado, C., Haas, P. J. & Brouns, S. J. J. Mechanisms and clinical importance of bacteriophage resistance. FEMS Microbiol. Rev. 46, fuab048 (2022).","DOI":"10.1093\/femsre\/fuab048"},{"key":"69154_CR26","doi-asserted-by":"crossref","unstructured":"Rohde, C. et al. Expert opinion on three phage therapy related topics: bacterial phage resistance, phage training and prophages in bacterial production strains. Viruses 10, 178 (2018).","DOI":"10.3390\/v10040178"},{"key":"69154_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.micpath.2016.08.001","volume":"99","author":"P Chadha","year":"2016","unstructured":"Chadha, P., Katare, O. P. & Chhibber, S. In vivo efficacy of single phage versus phage cocktail in resolving burn wound infection in BALB\/c mice. Micro. Pathog. 99, 68\u201377 (2016).","journal-title":"Micro. Pathog."},{"key":"69154_CR28","doi-asserted-by":"crossref","unstructured":"Huang, Y. et al. Phage products for fighting antimicrobial resistance. Microorganisms 10, 1324 (2022).","DOI":"10.3390\/microorganisms10071324"},{"key":"69154_CR29","doi-asserted-by":"crossref","unstructured":"Gu Liu, C. et al. Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry. mBio 11, e01462-20 (2020).","DOI":"10.1128\/mBio.01462-20"},{"key":"69154_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.15698\/mic2019.02.667","volume":"6","author":"P Chakraborty","year":"2019","unstructured":"Chakraborty, P. & Kumar, A. The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections? Micro. Cell 6, 105\u2013122 (2019).","journal-title":"Micro. Cell"},{"key":"69154_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep28701","volume":"6","author":"Q Li","year":"2016","unstructured":"Li, Q. et al. Mycobacteriophage SWU1 gp39 can potentiate multiple antibiotics against Mycobacterium via altering the cell wall permeability. Sci. Rep. 6, 28701 (2016).","journal-title":"Sci. Rep."},{"key":"69154_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.609017","volume":"11","author":"A Senhaji-Kacha","year":"2020","unstructured":"Senhaji-Kacha, A., Esteban, J. & Garcia-Quintanilla, M. Considerations for phage therapy against Mycobacterium abscessus. Front. Microbiol. 11, 609017 (2020).","journal-title":"Front. Microbiol."},{"key":"69154_CR33","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.cell.2022.04.024","volume":"185","author":"JA Nick","year":"2022","unstructured":"Nick, J. A. et al. Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection. Cell 185, 1860\u20131874.e1812 (2022).","journal-title":"Cell"},{"key":"69154_CR34","doi-asserted-by":"crossref","unstructured":"Kuipers, S., Ruth, M. M., Mientjes, M., de S\u00e9vaux, R. G. L. & van Ingen, J. A Dutch case report of successful treatment of chronic relapsing urinary tract infection with bacteriophages in a renal transplant patient. Antimicrob. Agents Chemother. 64, e01281-19 (2019).","DOI":"10.1128\/AAC.01281-19"},{"key":"69154_CR35","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.tim.2023.04.008","volume":"31","author":"K Champagne-Jorgensen","year":"2023","unstructured":"Champagne-Jorgensen, K., Luong, T., Darby, T. & Roach, D. R. Immunogenicity of bacteriophages. Trends Microbiol. 31, 1058\u20131071 (2023).","journal-title":"Trends Microbiol."},{"key":"69154_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cid\/ciac453","volume":"76","author":"RM Dedrick","year":"2023","unstructured":"Dedrick, R. M. et al. Phage therapy of Mycobacterium infections: compassionate use of phages in 20 patients with drug-resistant mycobacterial disease. Clin. Infect. Dis. 76, 103\u2013112 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"69154_CR37","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","volume":"9","author":"JP Pirnay","year":"2024","unstructured":"Pirnay, J. P. et al. Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat. Microbiol. 9, 1434\u20131453 (2024).","journal-title":"Nat. Microbiol."},{"key":"69154_CR38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","volume":"22","author":"DR Roach","year":"2017","unstructured":"Roach, D. R. et al. Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen. Cell Host Microbe 22, 38\u201347.e34 (2017).","journal-title":"Cell Host Microbe"},{"key":"69154_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4161\/bact.1.1.14942","volume":"1","author":"MR Clokie","year":"2011","unstructured":"Clokie, M. R., Millard, A. D., Letarov, A. V. & Heaphy, S. Phages in nature. Bacteriophage 1, 31\u201345 (2011).","journal-title":"Bacteriophage"},{"key":"69154_CR40","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3389\/fmicb.2017.00566","volume":"8","author":"F Navarro","year":"2017","unstructured":"Navarro, F. & Muniesa, M. Phages in the human body. Front. Microbiol. 8, 566 (2017).","journal-title":"Front. Microbiol."},{"key":"69154_CR41","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","volume":"25","author":"RM Dedrick","year":"2019","unstructured":"Dedrick, R. M. et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat. Med. 25, 730\u2013733 (2019).","journal-title":"Nat. Med."},{"key":"69154_CR42","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s41591-021-01403-9","volume":"27","author":"RM Dedrick","year":"2021","unstructured":"Dedrick, R. M. et al. Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection. Nat. Med. 27, 1357\u20131361 (2021).","journal-title":"Nat. Med."},{"key":"69154_CR43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.resmic.2018.04.008","volume":"169","author":"D Gelman","year":"2018","unstructured":"Gelman, D. et al. Combined bacteriophages and antibiotics as an efficient therapy against VRE Enterococcus faecalis in a mouse model. Res. Microbiol. 169, 531\u2013539 (2018).","journal-title":"Res. Microbiol."},{"key":"69154_CR44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1046\/j.1526-0968.2002.00413.x","volume":"6","author":"C Tetta","year":"2002","unstructured":"Tetta, C., Bellomo, R., Inguaggiato, P., Wratten, M. L. & Ronco, C. Endotoxin and cytokine removal in sepsis. Ther. Apher. 6, 109\u2013115 (2002).","journal-title":"Ther. Apher."},{"key":"69154_CR45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/archinte.1987.00370020155054","volume":"147","author":"MD Clayman","year":"1987","unstructured":"Clayman, M. D. et al. The Limulus amebocyte lysate assay. A rapid and sensitive method for diagnosing early gram-negative peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Arch. Intern. Med. 147, 337\u2013340 (1987).","journal-title":"Arch. Intern. Med."},{"key":"69154_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000168412","volume":"12","author":"G Peer","year":"1992","unstructured":"Peer, G., Serban, I., Blum, M., Cabili, S. & Iaina, A. Early diagnosis of gram-negative peritonitis in continuous ambulatory peritoneal dialysis patients with the Lymulus amebocyte lysate assay. Am. J. Nephrol. 12, 19\u201321 (1992).","journal-title":"Am. J. Nephrol."},{"key":"69154_CR47","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1177\/089686089701702S07","volume":"17","author":"A Breborowicz","year":"1997","unstructured":"Breborowicz, A. & Oreopoulos, D. G. Evidence for the presence of chronic inflammation during peritoneal dialysis: therapeutic implications. Perit. Dial. Int. 17, S37\u201341 (1997).","journal-title":"Perit. Dial. Int."},{"key":"69154_CR48","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.surg.2005.02.012","volume":"137","author":"T Matsuda","year":"2005","unstructured":"Matsuda, T. et al. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model. Surgery 137, 639\u2013646 (2005).","journal-title":"Surgery"},{"key":"69154_CR49","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3747\/pdi.2014.00313","volume":"36","author":"JH Crabtree","year":"2016","unstructured":"Crabtree, J. H. & Siddiqi, R. A. Simultaneous catheter replacement for infectious and mechanical complications without interruption of peritoneal dialysis. Perit. Dial. Int. 36, 182\u2013187 (2016).","journal-title":"Perit. Dial. Int."},{"key":"69154_CR50","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1046\/j.1525-139X.2002.00084.x","volume":"15","author":"MK Dasgupta","year":"2002","unstructured":"Dasgupta, M. K. Biofilms and infection in dialysis patients. Semin. Dial. 15, 338\u2013346 (2002).","journal-title":"Semin. Dial."},{"key":"69154_CR51","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/08968608221117315","volume":"42","author":"P Ye","year":"2022","unstructured":"Ye, P. et al. The application of metagenomic next-generation sequencing for detection of pathogens from dialysis effluent in peritoneal dialysis-associated peritonitis. Perit. Dial. Int. 42, 585\u2013590 (2022).","journal-title":"Perit. Dial. Int."},{"key":"69154_CR52","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/1751-7915.13826","volume":"15","author":"J Li","year":"2022","unstructured":"Li, J. et al. A rapid MALDI-TOF mass spectrometry-based method for colistin susceptibility testing in Escherichia\u2009coli. Micro. Biotechnol. 15, 528\u2013534 (2022).","journal-title":"Micro. Biotechnol."},{"key":"69154_CR53","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1111\/1751-7915.14124","volume":"15","author":"CH Yo","year":"2022","unstructured":"Yo, C. H. et al. MALDI-TOF mass spectrometry rapid pathogen identification and outcomes of patients with bloodstream infection: a systematic review and meta-analysis. Micro. Biotechnol. 15, 2667\u20132682 (2022).","journal-title":"Micro. Biotechnol."},{"key":"69154_CR54","doi-asserted-by":"crossref","unstructured":"Serena, T. E., Bowler, P. G., Schultz, G. S., D\u2019Souza, A. & Rennie, M. Y. Are semi-quantitative clinical cultures inadequate? Comparison to quantitative analysis of 1053 bacterial isolates from 350 wounds. Diagnostics 11, 1239 (2021).","DOI":"10.3390\/diagnostics11071239"},{"key":"69154_CR55","doi-asserted-by":"publisher","first-page":"e1011470","DOI":"10.1371\/journal.ppat.1011470","volume":"19","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. Temperature-dependent carrier state mediated by H-NS promotes the long-term coexistence of Y. pestis and a phage in soil. PLoS Pathog. 19, e1011470 (2023).","journal-title":"PLoS Pathog."},{"key":"69154_CR56","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fmicb.2020.00327","volume":"11","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. Development of a bacteriophage cocktail to constrain the emergence of phage-resistant Pseudomonas aeruginosa. Front. Microbiol. 11, 327 (2020).","journal-title":"Front. Microbiol."},{"key":"69154_CR57","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1080\/22221751.2021.1902754","volume":"10","author":"N Wu","year":"2021","unstructured":"Wu, N. et al. Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients. Emerg. Microbes Infect. 10, 612\u2013618 (2021).","journal-title":"Emerg. Microbes Infect."},{"key":"69154_CR58","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s11262-020-01766-0","volume":"56","author":"M Cheng","year":"2020","unstructured":"Cheng, M. et al. The characteristics and genome analysis of vB_ApiP_XC38, a novel phage infecting Acinetobacter pittii. Virus Genes 56, 498\u2013507 (2020).","journal-title":"Virus Genes"},{"key":"69154_CR59","first-page":"693","volume":"33","author":"L Str\u00f3j","year":"1999","unstructured":"Str\u00f3j, L., Weber-Dabrowska, B., Partyka, K., Mulczyk, M. & W\u00f3jcik, M. Successful treatment with bacteriophage in purulent cerebrospinal meningitis in a newborn. Neurol. Neurochir. Pol. 33, 693\u2013698 (1999).","journal-title":"Neurol. Neurochir. Pol."},{"key":"69154_CR60","doi-asserted-by":"crossref","unstructured":"Zaldastanishvili, E. et al. Phage therapy experience at the Eliava phage therapy center: three cases of bacterial persistence. Viruses 13, 1901 (2021).","DOI":"10.3390\/v13101901"},{"key":"69154_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.608402","volume":"10","author":"J Qin","year":"2020","unstructured":"Qin, J. et al. Heterogeneous Klebsiella pneumoniae co-infections complicate personalized bacteriophage therapy. Front. Cell Infect. Microbiol. 10, 608402 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"69154_CR62","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/cid\/ciz222","volume":"69","author":"R Nir-Paz","year":"2019","unstructured":"Nir-Paz, R. et al. Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination. Clin. Infect. Dis. 69, 2015\u20132018 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"69154_CR63","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/cid\/ciz782","volume":"70","author":"M Corbellino","year":"2020","unstructured":"Corbellino, M. et al. Eradication of a multidrug-resistant, carbapenemase-producing Klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom made, lytic bacteriophage preparation. Clin. Infect. Dis. 70, 1998\u20132001 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"69154_CR64","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13391","volume":"23","author":"OM Rostkowska","year":"2021","unstructured":"Rostkowska, O. M., Mi\u0119dzybrodzki, R., Miszewska-Szyszkowska, D., G\u00f3rski, A. & Durlik, M. Treatment of recurrent urinary tract infections in a 60-year-old kidney transplant recipient. The use of phage therapy. Transpl. Infect. Dis. 23, e13391 (2021).","journal-title":"Transpl. Infect. Dis."},{"key":"69154_CR65","doi-asserted-by":"crossref","unstructured":"Rubalskii, E. et al. Bacteriophage therapy for critical infections related to cardiothoracic surgery. Antibiotics 9, 232 (2020).","DOI":"10.3390\/antibiotics9050232"},{"key":"69154_CR66","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/22221751.2020.1747950","volume":"9","author":"J Bao","year":"2020","unstructured":"Bao, J. et al. Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae. Emerg. Microbes Infect. 9, 771\u2013774 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"69154_CR67","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1093\/cid\/ciaa705","volume":"73","author":"EJ Cano","year":"2021","unstructured":"Cano, E. J. et al. Phage therapy for limb-threatening prosthetic knee Klebsiella pneumoniae infection: case report and in vitro characterization of anti-biofilm activity. Clin. Infect. Dis. 73, e144\u2013e151 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"69154_CR68","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2340\/17453674.2022.4579","volume":"93","author":"JB Doub","year":"2022","unstructured":"Doub, J. B. et al. Salphage: salvage bacteriophage therapy for a recalcitrant Klebsiella pneumoniae prosthetic shoulder infection - a case report. Acta Orthop. 93, 756\u2013759 (2022).","journal-title":"Acta Orthop."},{"key":"69154_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27656-z","volume":"13","author":"A Eskenazi","year":"2022","unstructured":"Eskenazi, A. et al. Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae. Nat. Commun. 13, 302 (2022).","journal-title":"Nat. Commun."},{"key":"69154_CR70","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00037-23","volume":"67","author":"T Le","year":"2023","unstructured":"Le, T. et al. Therapeutic potential of intravenous phage as standalone therapy for recurrent drug-resistant urinary tract infections. Antimicrob. Agents Chemother. 67, e0003723 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"key":"69154_CR71","doi-asserted-by":"publisher","first-page":"1601.e1601","DOI":"10.1016\/j.cmi.2023.08.022","volume":"29","author":"J Li","year":"2023","unstructured":"Li, J. et al. Development of phage resistance in multidrug-resistant Klebsiella pneumoniae is associated with reduced virulence: a case report of a personalised phage therapy. Clin. Microbiol. Infect. 29, 1601.e1601\u20131601.e1607 (2023).","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69154-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69154-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69154-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:03:31Z","timestamp":1773677011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69154-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69154"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69154-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6855042\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2468"}}